Animalcare Group
Market Cap
UK£148.3m
Last Updated
2021/04/12 18:35 UTC
Data Sources
Company Financials +
Executive Summary
Animalcare Group plc engages in the development, sale, and distribution of licensed veterinary pharmaceuticals; and identification of products and services to companion animal veterinary markets in Spain, Portugal, Germany, Italy, other European Union, Asia, the Middle East, Africa, the United Kingdom, Belgium, the Netherlands, and internationally. More Details
Rewards
Risk Analysis
Snowflake Analysis
Flawless balance sheet with moderate growth potential.
Share Price & News
How has Animalcare Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ANCR is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: ANCR's weekly volatility (6%) has been stable over the past year.
Market Performance
7 Day Return
5.9%
ANCR
4.5%
GB Healthcare
2.4%
GB Market
1 Year Return
47.1%
ANCR
37.8%
GB Healthcare
23.6%
GB Market
Return vs Industry: ANCR exceeded the UK Healthcare industry which returned 37.8% over the past year.
Return vs Market: ANCR exceeded the UK Market which returned 23.6% over the past year.
Shareholder returns
| ANCR | Industry | Market | |
|---|---|---|---|
| 7 Day | 5.9% | 4.5% | 2.4% |
| 30 Day | 6.8% | 3.7% | 3.0% |
| 90 Day | 26.6% | 10.3% | 4.0% |
| 1 Year | 48.7%47.1% | 39.5%37.8% | 29.4%23.6% |
| 3 Year | -0.8%-6.5% | -13.5%-17.9% | 14.8%1.3% |
| 5 Year | n/a | -27.0%-32.1% | 40.4%14.0% |
Long-Term Price Volatility Vs. Market
How volatile is Animalcare Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall St
Animalcare Group (LON:ANCR) Is Reinvesting At Lower Rates Of Return1 month ago | Simply Wall St
An Intrinsic Calculation For Animalcare Group plc (LON:ANCR) Suggests It's 43% Undervalued1 month ago | Simply Wall St
If You Had Bought Animalcare Group's (LON:ANCR) Shares Three Years Ago You Would Be Down 27%Valuation
Is Animalcare Group undervalued compared to its fair value and its price relative to the market?
45.9%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ANCR (£2.47) is trading below our estimate of fair value (£4.63)
Significantly Below Fair Value: ANCR is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: ANCR is poor value based on its PE Ratio (634x) compared to the GB Healthcare industry average (30.9x).
PE vs Market: ANCR is poor value based on its PE Ratio (634x) compared to the UK market (25.7x).
Price to Earnings Growth Ratio
PEG Ratio: ANCR is poor value based on its PEG Ratio (14.5x)
Price to Book Ratio
PB vs Industry: ANCR's PB Ratio (1.8x) is in line with the GB Healthcare industry average.
Future Growth
How is Animalcare Group forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
43.8%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ANCR's forecast earnings growth (43.8% per year) is above the savings rate (1%).
Earnings vs Market: ANCR's earnings (43.8% per year) are forecast to grow faster than the UK market (21.5% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: ANCR's revenue (5.2% per year) is forecast to grow slower than the UK market (6.7% per year).
High Growth Revenue: ANCR's revenue (5.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ANCR's Return on Equity is forecast to be high in 3 years time
Past Performance
How has Animalcare Group performed over the past 5 years?
-27.3%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ANCR has a large one-off loss of £1.9M impacting its December 31 2020 financial results.
Growing Profit Margin: ANCR became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: ANCR has become profitable over the past 5 years, growing earnings by -27.3% per year.
Accelerating Growth: ANCR has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: ANCR has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (15.3%).
Return on Equity
High ROE: ANCR's Return on Equity (0.3%) is considered low.
Financial Health
How is Animalcare Group's financial position?
Financial Position Analysis
Short Term Liabilities: ANCR's short term assets (£29.8M) exceed its short term liabilities (£19.4M).
Long Term Liabilities: ANCR's short term assets (£29.8M) exceed its long term liabilities (£23.5M).
Debt to Equity History and Analysis
Debt Level: ANCR's debt to equity ratio (20.9%) is considered satisfactory.
Reducing Debt: ANCR's debt to equity ratio has reduced from 186.7% to 20.9% over the past 5 years.
Debt Coverage: ANCR's debt is well covered by operating cash flow (65.1%).
Interest Coverage: ANCR's interest payments on its debt are well covered by EBIT (5.3x coverage).
Balance Sheet
Dividend
What is Animalcare Group current dividend yield, its reliability and sustainability?
1.60%
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: ANCR's dividend (1.62%) is higher than the bottom 25% of dividend payers in the UK market (1.39%).
High Dividend: ANCR's dividend (1.62%) is low compared to the top 25% of dividend payers in the UK market (4.18%).
Stability and Growth of Payments
Stable Dividend: ANCR has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: ANCR has only been paying a dividend for 3 years, and since then payments have not increased.
Current Payout to Shareholders
Dividend Coverage: With its high payout ratio (1026.7%), ANCR's dividend payments are not well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: ANCR's dividends in 3 years are forecast to be well covered by earnings (31.3% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
3.8yrs
Average management tenure
CEO
Jenny Winter (60 yo)
2.5yrs
Tenure
UK£370,000
Compensation
Ms. Jennifer Ann Julia Winter, also known as Jenny, BSc serves as Chief Executive Officer at Animalcare Group plc since October 01, 2018 and its Director at October 1, 2018. She served as Vice President of...
CEO Compensation Analysis
Compensation vs Market: Jenny's total compensation ($USD507.75K) is about average for companies of similar size in the UK market ($USD561.27K).
Compensation vs Earnings: Jenny's compensation has been consistent with company performance over the past year.
Leadership Team
Experienced Management: ANCR's management team is considered experienced (3.8 years average tenure).
Board Members
Experienced Board: ANCR's board of directors are considered experienced (3.8 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Animalcare Group plc's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Animalcare Group plc
- Ticker: ANCR
- Exchange: AIM
- Founded: 1972
- Industry: Health Care Distributors
- Sector: Healthcare
- Market Cap: UK£148.341m
- Shares outstanding: 60.06m
- Website: https://www.animalcaregroup.co.uk
Number of Employees
Location
- Animalcare Group plc
- Unit 7, York Business Park
- 10 Great North Way
- York
- North Yorkshire
- YO26 6RB
- United Kingdom
Listings
Biography
Animalcare Group plc engages in the development, sale, and distribution of licensed veterinary pharmaceuticals; and identification of products and services to companion animal veterinary markets in Spain, ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/04/12 18:35 |
| End of Day Share Price | 2021/04/12 00:00 |
| Earnings | 2020/12/31 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.